CDK4/6-inhibiting drug substitutes for p21 and p16 in senescence: Duration of cell cycle arrest and MTOR activity determine geroconversion
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CDK4/6-inhibiting drug substitutes for p21 and p16 in senescence: Duration of cell cycle arrest and MTOR activity determine geroconversion
Authors
Keywords
-
Journal
CELL CYCLE
Volume 12, Issue 18, Pages 3063-3069
Publisher
Informa UK Limited
Online
2013-09-24
DOI
10.4161/cc.26130
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Normalizing a hyperactive mTOR initiates muscle growth during obesity
- (2016) David L. Williamson et al. Aging-US
- Molecular damage in cancer: an argument for mTOR-driven aging
- (2016) Mikhail V. Blagosklonny Aging-US
- Potential of mTOR inhibitors for the treatment of subependymal giant cell astrocytomas in tuberous sclerosis complex
- (2016) Philippe Major Aging-US
- Chemoprevention of age-related macular regeneration (AMD) with rapamycin
- (2016) X. F. Steven Zheng Aging-US
- Rapamycin as longevity enhancer and cancer preventative agent in the context of p53 deficiency
- (2016) Lawrence A. Donehower Aging-US
- Rapamycin extends lifespan and delays tumorigenesis in heterozygous p53+/− mice
- (2016) Elena A. Komarova et al. Aging-US
- Cell cycle arrest is not yet senescence, which is not just cell cycle arrest: terminology for TOR-driven aging
- (2016) Mikhail V. Blagosklonny Aging-US
- Rapamycin increases oxidative stress response gene expression in adult stem cells
- (2016) Amber E. Kofman et al. Aging-US
- New nanoformulation of rapamycin Rapatar extends lifespan in homozygous p53−/− mice by delaying carcinogenesis
- (2016) Maria Comas et al. Aging-US
- Phosphorylation of AKT: a Mutational Analysis.
- (2015) Jonathan R. Hart et al. Oncotarget
- Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascade Inhibitors: How Mutations Can Result in Therapy Resistance and How to Overcome Resistance
- (2015) James Andrew McCubrey et al. Oncotarget
- Late-life rapamycin treatment reverses age-related heart dysfunction
- (2013) James M. Flynn et al. AGING CELL
- Monitoring Tumorigenesis and Senescence In Vivo with a p16INK4a-Luciferase Model
- (2013) Christin E. Burd et al. CELL
- S6K in geroconversion
- (2013) Olga V. Leontieva et al. CELL CYCLE
- MEK drives cyclin D1 hyperelevation during geroconversion
- (2013) O V Leontieva et al. CELL DEATH AND DIFFERENTIATION
- mTOR in aging, metabolism, and cancer
- (2013) Marion Cornu et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Resveratrol potentiates rapamycin to prevent hyperinsulinemia and obesity in male mice on high fat diet
- (2013) O V Leontieva et al. Cell Death & Disease
- Rapamycin slows aging in mice
- (2012) John E. Wilkinson et al. AGING CELL
- Caveolin-1 and Accelerated Host Aging in the Breast Tumor Microenvironment
- (2012) Isabelle Mercier et al. AMERICAN JOURNAL OF PATHOLOGY
- Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice
- (2012) Vladimir N. Anisimov et al. CELL CYCLE
- Forever young? Exploring the link between rapamycin, longevity and cancer
- (2012) Michael Van Meter et al. CELL CYCLE
- Dissecting the role of mTOR complexes in cellular senescence
- (2012) Manuel Serrano CELL CYCLE
- A double whammy for aging? Rapamycin extends lifespan and inhibits cancer in inbred female mice
- (2012) Colin Selman et al. CELL CYCLE
- Rapamycin slows aging in mice
- (2012) Adam Spong et al. CELL CYCLE
- mTOR-independent 4E-BP1 phosphorylation is associated with cancer resistance to mTOR kinase inhibitors
- (2012) Yanjie Zhang et al. CELL CYCLE
- Autophagy and cardiovascular aging
- (2012) Sreejayan Nair et al. CELL CYCLE
- Attenuation of TORC1 signaling delays replicative and oncogenic RAS-induced senescence
- (2012) Marina Kolesnichenko et al. CELL CYCLE
- Hyper-mitogenic drive coexists with mitotic incompetence in senescent cells
- (2012) Olga V. Leontieva et al. CELL CYCLE
- The specific role of pRb in p16INK4A-mediated arrest of normal and malignant human breast cells
- (2012) Alexey V. Bazarov et al. CELL CYCLE
- The role of S6K1 in ER-positive breast cancer
- (2012) Marina K. Holz CELL CYCLE
- CDK inhibitors (p16/p19/p21) induce senescence and autophagy in cancer-associated fibroblasts, “fueling” tumor growth via paracrine interactions, without an increase in neo-angiogenesis
- (2012) Claudia Capparelli et al. CELL CYCLE
- mTOR Inhibition Prevents Epithelial Stem Cell Senescence and Protects from Radiation-Induced Mucositis
- (2012) Ramiro Iglesias-Bartolome et al. Cell Stem Cell
- Hypoxia suppresses conversion from proliferative arrest to cellular senescence
- (2012) O. V. Leontieva et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Contrasting Behavior of the p18INK4c and p16INK4a Tumor Suppressors in Both Replicative and Oncogene-Induced Senescence
- (2011) S. Gagrica et al. CANCER RESEARCH
- Rapamycin decelerates cellular senescence
- (2011) Zoya N. Demidenko et al. CELL CYCLE
- From growing to secreting: New roles for mTOR in aging cells
- (2011) Giovambattista Pani CELL CYCLE
- The meaning of p16ink4aexpression in tumors
- (2011) Agnieszka K. Witkiewicz et al. CELL CYCLE
- Senescence-associated heterochromatin foci are dispensable for cellular senescence, occur in a cell type- and insult-dependent manner and follow expression of p16ink4a
- (2011) Martin Kosar et al. CELL CYCLE
- Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
- (2011) Darren J. Baker et al. NATURE
- Elimination of Proliferating Cells Unmasks the Shift from Senescence to Quiescence Caused by Rapamycin
- (2011) Olga V. Leontieva et al. PLoS One
- Rapamycin Reverses Cellular Phenotypes and Enhances Mutant Protein Clearance in Hutchinson-Gilford Progeria Syndrome Cells
- (2011) K. Cao et al. Science Translational Medicine
- Rapamycin Extends Maximal Lifespan in Cancer-Prone Mice
- (2010) Vladimir N. Anisimov et al. AMERICAN JOURNAL OF PATHOLOGY
- Growth stimulation leads to cellular senescence when the cell cycle is blocked
- (2010) Zoya N. Demidenko et al. CELL CYCLE
- Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous Mice
- (2010) Richard A. Miller et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- mTOR: from growth signal integration to cancer, diabetes and ageing
- (2010) Roberto Zoncu et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Paradoxical suppression of cellular senescence by p53
- (2010) Z. N. Demidenko et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Anti-aging activity of theInk4/Arflocus
- (2009) Ander Matheu et al. AGING CELL
- mTOR Mediates Wnt-Induced Epidermal Stem Cell Exhaustion and Aging
- (2009) Rogerio M. Castilho et al. Cell Stem Cell
- Ribosomal Protein S6 Kinase 1 Signaling Regulates Mammalian Life Span
- (2009) C. Selman et al. SCIENCE
- Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
- (2008) Thomas Kuilman et al. CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now